Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAsJA-5zi6dJjp4usxaEBKAWNaMX5Gm4A0SaEJ2tXX3Bc#assertion>. }
Showing items 1 to 13 of
13
with 100 items per page.
- association type Statement assertion.
- context type Cohort assertion.
- MONDO_0005414 type Disease assertion.
- DRUGBANK:DB00363 type Drug assertion.
- association label "There are no FDA or manufacturer guidelines for use of clozapine in pediatric population. Clozapine has been used in the treatment of refractory schizophrenia in child and adolescents. It is estimated that 40%–50% of patients with very early-onset schizophrenia (VEOS) are nonresponders to first-line neuroleptics and that clozapine is likely to be beneficial." assertion.
- context label "Children and adolescents" assertion.
- association object MONDO_0005414 assertion.
- association predicate treats assertion.
- association subject DRUGBANK:DB00363 assertion.
- association relation OffLabelIndication assertion.
- association publications 31082865 assertion.
- association provided_by NeuroDKG assertion.
- association has_population_context context assertion.